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CoBACKGROUND Invasive fetal cardiac intervention (FCI) has been reported in single-institution series, promoting
technical and physiologic success.
OBJECTIVES This study describes the creation of an international registry of cases presenting for FCI, intended to
compile technical and outcome data from a multicenter cohort.
METHODS For this initial analysis, the entire database of the International Fetal Cardiac Intervention Registry (IFCIR)
was queried for details of diagnoses, procedures, and outcomes. Maternal-fetal dyads from January 2001 through June
2014 were included.
RESULTS Eighteen institutions submitted data by data harvest. Of 370 cases entered, 245 underwent FCI: 100 aortic
valvuloplasties from a previous single-center report (excluded from additional reporting here), an additional 86 aortic
and 16 pulmonary valvuloplasties, 37 atrial septal cases, and 6 unclassiﬁed cases. FCI did not appear to affect overall
survival to hospital discharge. Among live-born infants with a fetal diagnosis of aortic stenosis/evolving hypoplastic left
heart syndrome, more than twice as many were discharged with biventricular circulation after successful FCI versus those
meeting institutional criteria but without any or successful FCI (42.8% vs. 19.4%, respectively). When fetal deaths were
counted as treatment failures, the percentages were similar: biventricular circulation at discharge was 31.3% versus
18.5% for those discharged with univentricular palliation. Survival to discharge for live-born fetuses with atrial restriction
was similar to that of those undergoing technically successful versus unsuccessful FCI (63.6% vs. 46.7%, respectively),
although criteria for diagnosis were nonuniform.
CONCLUSIONS We describe the contents of the IFCIR and present post-natal data to suggest potential beneﬁt
to fetal therapy among pregnancies considered for possible intervention and support proposals for additional work.
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389AB BR E V I A T I O N S
AND ACRONYM S
AS = aortic stenosis
FAV = fetal aortic
valvuloplasty
FCI = fetal cardiac intervention
FPV = fetal pulmonary
valvuloplasty
HLHS = hypoplastic left heart
syndrome
PSþPA/IVS = severe
pulmonary stenosis and
pulmonary atresia with an
intact ventricular septum
REDCap = Research Electronic
Data CaptureC ongenital heart disease, which occurs inapproximately 6 of 1,000 live births (1), isthe most common cause of infant death due
to birth defect in the United States and other devel-
oped countries. The development of maternal-fetal
surgery techniques and advances in ultrasonography
technology have permitted treatment of some
congenital defects during fetal life (2,3). From a his-
torical perspective particular to cardiac intervention,
in 1991 Maxwell et al. (4) published their ﬁrst techni-
cally successful attempts to dilate the stenotic aortic
valve in 2 mid trimester fetuses, using balloon valvu-
loplasty via a needle inserted in the left ventricle,
aiming to prevent development of left heart hypopla-
sia. In 2004, a team from Boston showed feasibility
and moderate success in a series of fetal balloon
valvuloplasties for severe aortic stenosis (AS) (5).
Other fetal cardiac interventions were subsequently
described using a similar approach, speciﬁcally,
balloon pulmonary valvuloplasty for severe pulmo-
nary stenosis and pulmonary atresia with an intact
ventricular septum (PSþPA/IVS) (6,7), and atrial sep-
toplasty or stent placement for an intact or highly
restrictive atrial septum in fetuses with hypoplastic
left heart syndrome (HLHS) (8).SEE PAGE 400Following this pioneering work, an increasing
number of centers began offering fetal cardiac inter-
vention (FCI), primarily for midgestation severe AS,
which is thought, without intervention, to progress to
HLHS by term (9). Given the rarity of suitable cases,
prospective evaluation of outcomes with appropriate
control groups may be extremely difﬁcult. We there-
fore proposed initiation of an international registry
of procedures performed to date, with options for
both the retrospective and the prospective registra-
tion of candidates for fetal intervention (regardless of
whether a procedure was performed). Our premise
was that such a registry would allow for more rapid
accumulation of combined experience with FCI than a
single-center effort.
Thus, for this report, our main objective was
to describe the development and introduction of
a Research Electronic Data Capture (REDCap)of Medicine, Miami, Florida; ###Mount Sinai Hospital, University of Toro
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complete list of IFCIR contributors can be found in the Online Appendix
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Manuscript received February 23, 2015; revised manuscript received May 15database of pregnant women, their fetuses,
and infants evaluated at various international
programs as FCI candidates. Our secondary
objectives were to describe the content of the
new International Fetal Cardiac Intervention
Registry (IFCIR) after enrollment of most of
the eligible sites and completion of their case
entries and to compile data to support pro-
posals for additional publications and trials in
this area.
METHODS
The present study is the initial report of data
collected both retrospectively and prospec-
tively in the IFCIR. It is a voluntary registry
that collects pregnancy, perinatal, operative, and
perioperative data for patients (maternal/fetal dyads
and newborn infants) whom specialists believed
would beneﬁt from intervention based on fetal
echocardiographic criteria, including those who
eventually were not candidates because of other fetal
noncardiac conditions or maternal conditions or
preferences.
Collected data included basic demographic infor-
mation, descriptive anatomic diagnoses, associated
noncardiac or genetic anomalies, IFCIR-deﬁned fetal
procedures, pre-operative factors, maternal/fetal
intraoperative details, FCI and post-natal surgical
procedures performed, complications incurred at the
time of or after fetal intervention through the
remainder of pregnancy, technical success of the FCI
procedure (deﬁned as balloon dilation of the intended
target structure or stent placement with patency and
stable position at the conclusion of the procedure),
and in-hospital neonatal/infant mortality (through
to ﬁrst discharge). Diagnoses and procedures were
entered by clinicians and afﬁliated data managers. A
complete list of data collected is available in the
Online Appendix. Procedures included perventricular
fetal aortic valvuloplasty (FAV), perventricular fetal
pulmonary valvuloplasty (FPV), and transatrial fetal
atrial septoplasty and/or stent placement. Fetal
pacemaker implantation and therapeutic hyperoxia
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TABLE 1 Suggested Preoperative Echocardiographic Criteria*†
With Threshold Z Scores‡ for Performance of Balloon
Valvuloplasty§
1. Dominant cardiac anatomic anomaly: valvular aortic stenosis with all
of the following:
 Decreased mobility of valve leaﬂets
 Antegrade Doppler color ﬂow jet across aortic valve smaller
than valve annulus diameter
 No or minimal subvalvular LV outﬂow obstruction
2. LV function qualitatively depressed
3. Either retrograde or bidirectional ﬂow in the transverse aortic arch
or 2 of the following:
 Monophasic mitral inﬂow Doppler pattern
 Left-to-right ﬂow across atrial septum or intact atrial septum
 Bidirectional ﬂow in pulmonary veins
4. LV long-axis Z score $2
5. Threshold score >4 (fulﬁlling >4 of the following)
 LV long-axis Z score >0 (1 point)
 LV short-axis Z score >0 (1 point)
 Aortic annulus Z score $3.5 (1 point)
 Mitral valve annulus Z score of $2 (1 point)
 Mitral regurgitation or aortic outﬂow peak systolic gradient
>20 mm Hg (1 point)
*Criteria are presented in table form for completeness. Registry retrospective
analysis considered only decreased left ventricular function, retrograde aortic arch
Doppler ﬂow, and left-to-right atrial shunting as necessary and a decision to
intervene as sufﬁcient. †All criteria (1–5) must be met in original description. ‡Z
scores were published in an online data supplement to McElhinney et al. (29).
§Shown are data for mid trimester fetuses (18 to 32 weeks of age) with severe
aortic stenosis associated with a high likelihood of post-natal biventricular repair
after fetal intervention (data from McElhinney et al. [29] and Oepkes et al. [10]).
LV ¼ left ventricular.
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390in the initial data harvest. For this initial report, data
that had been entered as of June 2014 were queried.
DATABASE DESIGN AND DATA ENTRY PROTOCOL.
Approximately 25 fetal surgery and fetal interven-
tional programs worldwide initially committed to
or expressed interest in contributing data to this
effort (10). Beginning in 2011, a World Wide Web-
based REDCap database was launched, designed by
University of California-San Francisco (UCSF) site
participants with content and structural input from
the other collaborators over a 6-month period. Local
data entry personnel were identiﬁed and assigned
unique, secure sign-in credentials and received tele-
phone or Web-based training. Data from all consecu-
tive cases undergoing evaluation for FCI since 2001
were requested. During data entry, sites were granted
access only to their own data by use of a “Data Access
Group” function in REDCap. In rare cases involving
referral of a patient across centers, data entry
personnel were asked to communicate with each
other and avoid duplicate entries. Patients sent from
a nonintervention center to an intervention center
were entered by the center performing the interven-
tion only.
UCSF serves as the administrative and data-
coordinating center for IFCIR and obtained institu-
tional review board (IRB) approval for the project.
Individuals and participating member sites (see
complete list in Online Appendix) obtained local IRB
and ethics board approval or a waiver, as governed by
applicable local legal and research standards.
De-identiﬁed study data were entered remotely at
the local institutions and collected and managed us-
ing REDCap electronic data capture tools hosted at
UCSF (11). REDCap is a Web-based application
designed to support data capture for research studies.
STATISTICAL ANALYSIS. Data analysis was per-
formed at the UCSF administrative center site and at
the data analysis center at Baylor College of Medicine,
using SPSS Statistics version 22.0 software (IBM,
Armonk, New York) for Windows (Microsoft, Red-
mond, Washington). Maternal, fetal, and neonatal
outcomes were described using standard summary
statistics and nonparametric testing as appropriate.
Frequencies are reported along with percentages, and
means with SD and medians with interquartile ranges
are reported. Patients with missing data were
excluded from analyses involving that variable but
were included in the overall reporting as appropriate.
Additional analyses were considered exploratory
and not subjected to statistical analysis; we per-
formed simple evaluations, with important limita-
tions (primarily lack of true case-control design), of
overall outcomes for 2 diagnostic groups: fetuses withAS and fetuses with HLHS and a highly restrictive or
intact atrial septum. Two tallies were performed for
each diagnostic group. First, an intention-to-treat
analysis that contrasted the outcomes of all fetuses
in the FCI group versus a group meeting criteria but
who did not undergo FCI (Table 1). In this instance,
fetal periprocedural demise or late intrauterine
demise was regarded as a failed outcome. Given the
expected wide variation in center experience and
different levels of skill associated with different
technical success rates and procedure-related fetal
mortality, a second tally for each diagnostic group
was performed. In this second analysis, only those
live-born infants with technically successful FCI were
included and then contrasted with live-born infants
who met criteria but who either did not have FCI or
who had a technically unsuccessful FCI. This allowed
an estimate of outcomes under ideal circumstances,
with all FCI achieving technical success without any
fetal deaths. The entire exploratory exercise was
designed to provide a general overview of the range
of outcomes among patients considered for inter-
vention. Pregnancies resulting in elective termination
were excluded from the analyses.
CRITERIA FOR ENTRY INTO EXPLORATORY ANALYSIS.
The fetal AS group included fetuses who were
deemed candidates for FAV by the participating
FIGURE 1 Registry Entries by Year of Evaluation
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Of 370 total entries of maternal-fetal dyads, 100 were censored from the ﬁgure (single
center, previously published [27]). *Only through June 1, 2014. FCI ¼ fetal cardiac
intervention.
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391center and who satisﬁed the critical elements of the
published criteria (Table 1) for FCI: decreased left
ventricular function, retrograde aortic arch Doppler
ﬂow, and left-to-right atrial shunting. The primary
outcome for the fetal AS patients was the percentage
of infants discharged alive who had biventricular
circulation. In the intention-to-treat analysis of all
patients, fetal periprocedural demise or late intra-
uterine demise counted as “not biventricular.”
Although natural history data existed for prenatal
prediction of post-natal poor outcome in cases of
restrictive interatrial septum (12–14) or for uni-
ventricular circulation for pulmonary valve obstruc-
tion (15–18), there are no currently accepted criteria
for fetal atrial septoplasty, atrial stent placement,
or pulmonary valvuloplasty. Thus, fetuses were con-
sidered appropriate candidates if they were under-
going FCI or if were not undergoing intervention for
noncardiac reasons (e.g., maternal contraindication,
patient preference, and others). For atrial procedure
candidates, the primary outcome was survival to
discharge. For the purposes of reporting of these pa-
tients, fetal periprocedural demise or late fetal death
counted as a discharge mortality.
RESULTS
In its ﬁrst year, the database received entries from 4
institutions, with an additional 4 to 5 new institutions
entering data per year for a total of 9 in 2012, 13 in
2013, and 18 in 2014. At the time of this report,
there were approximately 60 actively participating
individuals and a 37-member steering committee,
representing 40 institutions in 15 countries. Six Eu-
ropean countries were unable to enter data for FAV
procedures due to their concurrent participation in a
separate clinical trial.
Two U.S. centers entered only previously published
data (currently in the public domain) and were exempt
from IRB and data use agreement requirements. One
center’s regulatory body declined to enter into the
data-use agreement despite local IRB approval, and
the remainder have active data-use agreements with
the IFCIR. All centers obtained local IRB approval or a
legal waiver (or both) for the project; additionally, 2
centers required IRB-approved research consent to be
signed by patients for the procedure, and 3 centers
obtained prospective written consent for data collec-
tion from patients at the time of the procedure. Eight
centers’ local regulations did not require any special
consent procedures, as the fetal intervention was
considered clinical care.
The total number of cases (FCI and noninterven-
tion) entered each year are shown in Figure 1. Eightinstitutions entered only intervention cases, 3 en-
tered only nonintervention cases due to FCI not being
offered at those locations, and 7 entered all cases
presenting, whether FCI was performed or not. Of the
institutions entering both types of patients, the
lowest FCI rate was 4% and the highest was 85%
(median: 42%). Of the 15 centers entering FCI cases,
case volume (total, not per year) ranged from 1 to 132;
7 centers reported 3 or fewer cases, 3 reported be-
tween 5 and 10 cases, 3 reported 11 to 20 cases, and 2
each reported more than 20 cases. Twelve centers
performed FAV, 8 performed FPV, 8 performed atrial
septoplasty/septostomy, and 4 performed atrial
septal stent procedures. Seven centers had performed
only 1 type of procedure, usually FAV.
CASES. At the time of data harvest (June 2014), there
were 370 unique records of maternal/fetal dyads in
the registry. Forty-one cases that had been previously
reported in single-center case reports or small series
were included (19–26), including 15 aortic valvulo-
plasties, 8 pulmonary valvuloplasties, and 18 atrial
septal procedures. One hundred cases of AS from a
single institution were subjects of a recent compre-
hensive report (27) and were censored from the pre-
sent report to remove overlap and thus facilitate
comparison of the IFCIR cohort to that report. Data
TABLE 2 Fetal Cardiac Intervention Registry Patient Entries, Including Basic Demographics
N
Median GA at
Evaluation (range)†
Median GA at
Birth (range) Birth Weight (g)
Total patients referred 370
Total for this report* 270
Intervention 145 25 (18–36), n ¼ 145† 38 (29–40), n ¼ 76 2,970 (1,035–4,150), n ¼ 73
No intervention 125 22 (16–38), n ¼ 114‡ 38 (27–40), n ¼ 69 2,957 (1,445–4,200), n ¼ 62
Excessive maternal or fetal risk 8
Pregnancy termination 27
Maternal contraindication 9
Not fetal candidate 51
Chose postnatal care 15
No reason given 3
*100 patients from a single center (27) were excluded from this table. †p ¼ 0.01, Mann-Whitney U test. ‡p ¼ 0.99 when termination of pregnancy cases (n ¼ 42)
were excluded.
FCI ¼ fetal cardiac intervention; GA ¼ gestational age.
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392regarding fetal gestational age at referral and at birth
in the remaining 270 patients are presented in
Table 2, as are reasons for nonintervention in preg-
nant women referred for evaluation. The youngest
maternal age at which fetal intervention was consid-
ered was 16 years of age, but the youngest maternal
age recorded for actual FCI was 18 years of age. Nearly
one-half of those fetuses evaluated did not undergo
FCI, either because they were not deemed candi-
dates by the centers entering the data or the families
declined intervention. Maternal contraindications for
FCI were cited in 9 cases, and there was a perception
of excessive risk to mother or fetus in another 8 cases.
FCI was attempted in 145 patients. Procedural
complications and pregnancy outcomes are presented
in Table 3.
Data regarding FCI access type were missing in 9
entries (3 from a single institution). Of the remaining
136 cases, only a single case done via hysterotomy (in
2002) was recorded. Most cases were performed
percutaneously; only 9 women underwent laparot-
omy or mini-laparotomy, and all but 2 of these
occurred prior to 2010; 1 each in 2012 and 2013 were
done for AS, both of which were technically unsuc-
cessful despite the laparotomy.
Data regarding FCI maternal/fetal anesthesia type
were missing from only 7 cases (3 from 1 institution).
Most of the 138 cases in which anesthesia was speci-
ﬁed were performed without general anesthesia
(n ¼ 109 [79%]), and only 3 of 78 cases (4%) since 2010
have had general anesthesia (the 2 centers that
reported general anesthesia use in recent years used
it in a minority of their cases). The remainder were
done with regional (spinal or epidural [n ¼ 68]), local
([n ¼ 39] type not speciﬁed), or both (n ¼ 2) for themother. All except 4 of the 134 fetuses with data
regarding intraprocedural medications (97%)
received analgesia, and all of these received neuro-
muscular blockade.
EXPLORATORY ANALYSES. According to pregnancy
and discharge outcomes for all fetuses evaluated for
aortic valvuloplasty (Figure 2), fetal survival (to live
birth only; pregnancy termination and lost to follow-
up were excluded) was 80.0% in the FCI group and
85.2% in the non-FCI group. Fetal death was attrib-
uted to periprocedural demise more often in the FCI
group and to intrauterine demise more commonly
in the nonintervention group. Overall neonatal dis-
charge survival (any circulatory status) was 57.5% in
the FCI group and 59.3% in the non-FCI group. Among
live-born infants, survival to hospital discharge was
75.0% in the technically successful FCI group and
67.7% in the combined non-FCI and technically un-
successful FCI group.
More fetuses were ultimately discharged alive
with biventricular circulation when FCI had been
attempted: biventricular circulation in 31.3% (25 of 80
cases) of FCI versus 18.5% (5 of 27 cases) of the non-
FCI group. When limited to only live-born infants,
the comparison of those with a technically successful
intervention versus those in whom there was no FCI
or the intervention was technically unsuccessful,
there was the suggestion of improved survival to
discharge with biventricular circulation: 42.9% (24 of
56) versus 19.4% (6 of 31), respectively.
Of fetuses considered for atrial septal interven-
tion in HLHS, 37 underwent FCI, and 6 were consi-
dered candidates but did not undergo intervention
(Figure 3); no differences were seen in overall dis-
charge survival rates (50% [18 of 36] for FCI vs. 50%
TABLE 3 Pregnancy Outcomes Among FCI Patients by Procedure Type
Parameter Total Aortic Valvuloplasty
Pulmonary
Valvuloplasty
Atrial Septoplasty
With or Without a Stent Other
Maternal-fetal patients 145 86 16 37 6
GA at intervention (weeks) 26.4 (19.3–36.4) 25.0 (19.3–34.4) 26.0 (23.0–29.6) 30.0 (22.9–36.1) 29.0 (24.6–36.4)
Complications
Fetal death 16 (11) 10 2 3 1
Bradycardia requiring treatment 47 (32) 29 7 10 1
Hemopericardium requiring drainage 42 (29) 16 9 16 1
Balloon rupture 6 (4) 4 1 1 0
Maternal complication 0
Pregnancy outcome post-intervention
Termination 6 (4) 6 0 0 0
Periprocedural demise (<48 h) 9 (6) 5 2 2 0
Late intrauterine demise 2 (1) 1 0 1 0
Term birth 77 (53) 49 5 21 2
Preterm birth (<37 weeks) birth 29 (20) 15 4 8 2
Not stated/in utero 6 0 3 2 1
Survival to ﬁrst hospital discharge 71 (49) 46 6 18 1
Values are n, median (interquartile range), or n (%).
Abbreviations as in Table 2.
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393[3 of 6] with no FCI). Comparing only live-born infants
following technically successful FCI with live-born
infants without fetal procedure success, there were,
again, no apparent differences in survival rates: 63.6%
(14 of 22) of successful FCI versus 46.7% (7 of 15),
respectively, of all others.
Of 30 fetuses considered for FPV, 16 underwent
FCI, and 8 met institutional criteria but did not un-
dergo intervention (Figure 4). Of these, 42.9% (6 of 14)
of those undergoing FCI and 37.5% (3 of 8) of those
without intervention were discharged with biven-
tricular circulation.
DISCUSSION
Since the initial proposal for the IFCIR in 2010,
a robust data collection tool has been created and
vetted among the participating institutions. De-
mographic data including maternal age, ethnicity,
country of origin, comorbidities, and gestational age
at referral have been systematically collected. Preg-
nancy and neonatal outcome data including physio-
logical success or failure of fetal procedure with a
separate population of referrals who did not ulti-
mately undergo FCI were catalogued and are the
subject of this initial report.
Our registry data regarding overall procedure-
related complication and loss rates (Central
Illustration) are similar to those previously reported
in smaller series (28,29). Fetal death during the
procedure is not uncommon (11%) and occurred
across all procedure types. Additionally, early post-procedural (<48 h) fetal demise was an issue in this
dataset. These rates, which are higher than those
previously published in single-center experiences
with FCI, likely represent a combination of different
learning curves combined with the known compli-
cations of any invasive intervention in a compro-
mised fetus (30). Fetal intraprocedural complication
rates remain high, with bradycardia and hemoper-
icardium requiring drainage occurring in a signiﬁ-
cant number of cases and across all procedure types,
underlining the need for a team of experienced
maternal/fetal, pediatric cardiology, and surgical
practitioners whenever these cases are performed.
The precise number of procedures and types of per-
sonnel needed for a successful center have yet
to be determined, but analysis of registry data,
including that in the IFCIR, may help us gain insight
into the learning curve and the minimum number of
cases needed to obtain initial, and maintain ongoing,
proﬁciency (31).
For FAV, technical difﬁculties were initially the
limiting factor, but more recently published proce-
dural success rates are in the 80% range (27). Pub-
lished data from Austria demonstrated a procedural
success rate of 78.6% in more recent years, with pro-
cedural success in 10 of 15 fetuses (66.7%) achieving
biventricular circulation post-natally (28). Neither the
patients in the recently published Boston series (27)
nor the Linz series (28) were included in this report
(although the Boston patients are in the IFCIR, they
were excluded from the original data analysis),
allowing valid comparison of these separate cohorts.
FIGURE 2 Fetal Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome
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Post-natal data are limited to live births at the time of data query (June 2014). Those subjects denoted by entering center as not meeting
criteria and those who failed to meet critical elements of published criteria for FCI (including decreased left ventricular function, retrograde
or bidirectional transverse aortic arch ﬂow, and left-to-right atrial shunt) comprise the 37 who “did not meet fetal criteria.” All other
fetuses who did not undergo FCI (n¼ 29) were included in the outcome analysis. Bi-V ¼ biventricular; DC ¼ hospital discharge; FAV¼ fetal aortic
valvuloplasty; FCI ¼ fetal cardiac intervention; IUFD ¼ intrauterine fetal demise; LTFU ¼ lost to follow-up; single V ¼ univentricular
palliation done; TOP ¼ termination of pregnancy.
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394Therefore, it is interesting to note that the biven-
tricular circulation rates noted in our exploratory
analysis in the IFCIR (31.3% of all procedural suc-
cesses; 42.8% of live-born infants with technical suc-
cess) for fetuses undergoing aortic valve dilation aresimilar to those in these single-center series. This
suggests that, at least in the hands of experienced
fetal medicine centers with appropriate personnel and
team-based skill sets for maternal-fetal intervention
(and despite likely different approaches to post-natal
FIGURE 3 Fetal Restrictive or Intact Atrial Septum
RESTRICTIVE OR INTACT ATRIAL SEPTUM IN HLHS
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5
FCI not available
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1
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Post-natal data are limited to live births at the time of data query (June 2014). FASI ¼ fetal atrial septal intervention; HLHS ¼ hypoplastic left
heart syndrome; other abbreviations are as in Figure 2.
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395surgical approaches to borderline patients), similar
results can be obtained despite lower procedural vol-
umes. Procedure-related and patient-speciﬁc factors
that may inﬂuence additional confounding are clearly
issues that could be further investigated with a more
mature dataset using this registry approach. Addi-
tionally, analysis of the volume/outcomes relation-
ship will be crucial to answer questions regarding
whether these procedures should be centralized to a
few institutions worldwide (31).HLHS with intact or restrictive atrial septum, a
variant of HLHS, results in a severely abnormal fetal
blood ﬂow pattern, ultimately leading to a signiﬁcant
increase in perinatal mortality despite aggressive
post-natal intervention. An initial report of attempts
to intervene during fetal life to relieve the obstruction
caused by the restrictive atrial septum demonstrated
the procedure’s technical feasibility but failed to
demonstrate a beneﬁt in overall survival (8). More
recently, however, the same group showed that
FIGURE 4 Fetal Pulmonary Valve Stenosis and Atresia
PULMONARY STENOSIS/ATRESIA WITH INTACT VENTRICULAR SEPTUM
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Post-natal data are limited to live births at the time of data query (June 2014). FPV ¼ fetal pulmonary valvuloplasty; other abbreviations as in
Figure 2.
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396decompression of the left atrium via fetal aortic
valvuloplasty or atrial septoplasty may be associated
with increased hospital survival (32). Our registry
now includes more than 37 patients who had
FCI subsequent to the experience published by
Marshall et al. (8) in 2004 and several potential
“controls”; further analysis of these patients is
ongoing and will be the subject of a separate report.A complex disease spectrum, PSþPA/IVS, is usually
associated with various degrees of underdevelopment
of the right ventricle. Some centers have reported
success with the procedure with post-natal survivors
suitable for a 2-ventricle repair (20,25,33). Our registry
data conﬁrm the possibility of technical success, but
there is no consensus on how to accurately predict
the likelihood of a successful biventricular repair in
CENTRAL ILLUSTRATION International Fetal Cardiac Intervention Registry Cases
Moon-Grady, A.J. et al. J Am Coll Cardiol. 2015; 66(4):388–99.
With 18 institutions submitting data, the International Fetal Cardiac Intervention Registry includes details of diagnosis, procedures, and outcomes of maternal-fetal
dyads, including overall cases (A) and those undergoing attempted aortic valvuloplasty (B), septoplasty or stenting (C) and pulmonary valvuloplasty (D).
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397PSþPA/IVS fetuses, and some of the “successful” FCIs
may not have been necessary to achieve biventricular
outcomes.
Enthusiasm for fetal intervention must be
tempered by mindfulness of the interests of the
mother and her family, by careful study of the natural
history of the disease in untreated human fetuses,
and by a willingness to abandon therapy that does not
prove effective and safe in properly performed trials.
To date, clinical results of maternal/fetal intervention
for AS are based on comparisons with historical con-
trols and address efﬁcacy rather than safety (28,29).
Many argue that only a properly designed, adequately
powered, and meticulously conducted prospective
trial, ideally randomized, would sufﬁciently over-
come bias. The counterargument is that, given avail-
able data that show in well-selected cases whichpatients were highly likely to evolve to HLHS and
those who were born with a nearly normal-sized left
ventricle after fetal valvuloplasty, denying FCI would
be unethical. Collaborative efforts such as the IFCIR
may represent a reasonable compromise given a lack
of equipoise.
STUDY LIMITATIONS. Although this report provides
important information, it also demonstrates the
strengths and weaknesses of databases in general
and the IFCIR in particular. Registries such as this
can help provide information regarding the scope
and variety of treatment options, as well as imme-
diate outcomes, in cases of rare diseases; however,
the absence of preoperative hemodynamic and uni-
formly obtained echocardiographic data and long-
term follow-up preclude high-quality comparisons
among different management strategies. As the
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE:
Relatively few congenital structural cardiac anomalies
are amenable to currently available FCI procedures,
which are available in a small number of centers
around the world. These invasive procedures have
been associated with a high rate of initial technical
success and low maternal risk but considerable fetal
morbidity and mortality.
COMPETENCY IN PATIENT CARE AND
PROCEDURAL SKILLS: Maternal candidates for
fetal cardiac intervention should be informed of the
risks and potential complications associated with
these invasive procedures and of the uncertainty
regarding long-term outcomes for the child.
TRANSLATIONAL OUTLOOK: Future efforts in
this international collaboration will focus on evalu-
ating the relationships between procedural volume,
short-term clinical outcomes, and longer-term func-
tional and neurodevelopmental status of infant sur-
vivors of fetal cardiac procedures.
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398current report serves to provide an initial overview
of the IFCIR, the data analysis is largely descriptive.
There is only limited ability to infer from and then
extrapolate this study’s ﬁndings beyond a popula-
tion speciﬁcally referred for possible intervention.
Another limitation is the suggestion that patients
referred for fetal intervention but who ultimately do
not undergo FCI may serve as a proper “control”
group. Although we present numerical data that
might facilitate such comparisons, this limitation
should be carefully considered when drawing con-
clusions from our presentation of intervention versus
nonintervention cohorts. Further, because of our
referral center-based enrollment and lack of complete
follow-up for patients not born at our centers, the
registry provides very limited and potentially biased
data on post-natal clinical status and any post-natal
procedures that may have been performed.
Despite these apparent weaknesses and the lack of
standardization, we still have the ability to draw
some strong conclusions from the IFCIR database. For
example, general anesthesia is essentially no longer
used, and all technically successful procedures in the
recent era have been done without laparotomy. This
illustrates a clear evolution in the ﬁeld of FCI toward
less maternal morbidity.
CONCLUSIONS
Many centers worldwide are conducting FCIs, with the
most common procedure being aortic valvuloplasty,
although short- and long-term risks and beneﬁts
remain largely unclear despite our efforts. Because of
the inherent logistical and practical impediments to an
international, multicenter, randomized controlled
trial, we believe the IFCIR project provides an impor-
tant resource for those working in this ﬁeld. The
database may help to move the group toward
consensus in terms of indication, patient selection,
and procedural technique and to establish a minimalprocedural dataset addressing outcome parameters.
Linkage to pediatric congenital heart surgery and
disease databases may be practical and technically
feasible and may constitute a valid next step.
ACKNOWLEDGMENT The authors acknowledge the
expert assistance of Katie Archbold in support of this
project and the manuscript.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Anita J. Moon-Grady, Division of Pediatric Cardiol-
ogy, University of California, San Francisco, Box
0544, 550 16th Street, 5th Floor, San Francisco,
California 94158. E-mail: anita.moongrady@ucsf.edu.RE F E RENCE S1. Hoffman JI, Kaplan S. The incidence of
congenital heart disease. J Am Coll Cardiol 2002;
39:1890–900.
2. Adzick NS, Thom EA, Spong CY, et al.
A randomized trial of prenatal versus postnatal
repair of myelomeningocele. N Engl J Med 2011;
364:993–1004.
3. Harrison MR, Keller RL, Hawgood SB, et al.
A randomized trial of fetal endoscopic tracheal
occlusion for severe fetal congenital diaphrag-
matic hernia. N Engl J Med 2003;349:1916–24.
4. Maxwell D, Allan L, Tynan MJ. Balloon dilata-
tion of the aortic valve in the fetus: a report of two
cases. Br Heart J 1991;65:256–8.5. Tworetzky W, Wilkins-Haug L, Jennings RW,
et al. Balloon dilation of severe aortic stenosis in
the fetus: potential for prevention of hypoplastic
left heart syndrome: candidate selection, tech-
nique, and results of successful intervention.
Circulation 2004;110:2125–31.
6. Galindo A, Gutierrez-Larraya F, Velasco JM, de
la Fuente P. Pulmonary balloon valvuloplasty in a
fetus with critical pulmonary stenosis/atresia with
intact ventricular septum and heart failure. Fetal
Diagn Ther 2006;21:100–4.
7. Tulzer G, Arzt W, Franklin RC, Loughna PV,
Mair R, Gardiner HM. Fetal pulmonary valvu-
loplasty for critical pulmonary stenosis oratresia with intact septum. Lancet 2002;360:
1567–8.
8. Marshall AC, van der Velde ME, Tworetzky W,
et al. Creation of an atrial septal defect in utero for
fetuses with hypoplastic left heart syndrome and
intact or highly restrictive atrial septum. Circula-
tion 2004;110:253–8.
9. Makikallio K, McElhinney DB, Levine JC, et al.
Fetal aortic valve stenosis and the evolution of
hypoplastic left heart syndrome: patient selection
for fetal intervention. Circulation 2006;113:
1401–5.
10. Oepkes D, Moon-Grady AJ, Wilkins-Haug L,
Tworetzky W, Arzt W, Devlieger R. 2010 Report
J A C C V O L . 6 6 , N O . 4 , 2 0 1 5 Moon-Grady et al.
J U L Y 2 8 , 2 0 1 5 : 3 8 8 – 9 9 International Fetal Cardiac Intervention Registry
399from the ISPD Special Interest Group fetal therapy:
fetal cardiac interventions. Prenat Diagn 2011;31:
249–51.
11. Harris PA, Taylor R, Thielke R, Payne J,
Gonzalez N, Conde JG. Research electronic data
capture (REDCap)—a metadata-driven methodol-
ogy and workﬂow process for providing trans-
lational research informatics support. J Biomed
Inform 2009;42:377–81.
12. Lowenthal A, Kipps AK, Brook MM, Meadows J,
Azakie A, Moon-Grady AJ. Prenatal diagnosis of
atrial restriction in hypoplastic left heart syndrome
is associated with decreased 2-year survival. Pre-
nat Diagn 2012;32:485–90.
13. Michelfelder E, Gomez C, Border W,
Gottliebson W, Franklin C. Predictive value of fetal
pulmonary venous ﬂow patterns in identifying the
need for atrial septoplasty in the newborn with
hypoplastic left ventricle. Circulation 2005;112:
2974–9.
14. Rychik J, Rome JJ, Collins MH, DeCampli WM,
Spray TL. The hypoplastic left heart syndrome
with intact atrial septum: atrial morphology, pul-
monary vascular histopathology and outcome.
J Am Coll Cardiol 1999;34:554–60.
15. Gardiner HM, Belmar C, Tulzer G, et al.
Morphologic and functional predictors of eventual
circulation in the fetus with pulmonary atresia or
critical pulmonary stenosis with intact septum.
J Am Coll Cardiol 2008;51:1299–308.
16. Gomez-Montes E, Herraiz I, Mendoza A,
Albert L, Hernandez-Garcia JM, Galindo A. Pul-
monary atresia/critical stenosis with intact ven-
tricular septum: prediction of outcome in the
second trimester of pregnancy. Prenat Diagn 2011;
31:372–9.
17. Lowenthal A, Lemley B, Kipps AK, Brook MM,
Moon-Grady AJ. Prenatal tricuspid valve size as a
predictor of postnatal outcome in patients with
severe pulmonary stenosis or pulmonary atresia
with intact ventricular septum. Fetal Diagn Ther
2014;35:101–7.18. Salvin JW, McElhinney DB, Colan SD, et al.
Fetal tricuspid valve size and growth as predictors
of outcome in pulmonary atresia with intact ven-
tricular septum. Pediatrics 2006;118:e415–20.
19. Chaturvedi RR, Ryan G, Seed M, van Arsdell G,
Jaeggi ET. Fetal stenting of the atrial septum:
technique and initial results in cardiac lesions with
left atrial hypertension. Int J Cardiol 2013;168:
2029–36.
20. Gomez Montes E, Herraiz I, Mendoza A,
Galindo A. Fetal intervention in right outﬂow tract
obstructive disease: selection of candidates and
results. Cardiol Res Pract 2012;2012:592403.
21. Huhta J, Quintero RA, Suh E, Bader R. Ad-
vances in fetal cardiac intervention. Curr Opin
Pediatr 2004;16:487–93.
22. Kalish BT, Tworetzky W, Benson CB, et al.
Technical challenges of atrial septal stent place-
ment in fetuses with hypoplastic left heart syn-
drome and intact atrial septum. Catheter
Cardiovasc Interv 2014;84:77–85.
23. Marantz P, Aiello H, Grinenco S, et al. Fetal
aortic valvuloplasty: experience of ﬁve cases.
Cardiol Young 2013;23:675–81.
24. Moon-Grady AJ, Moore P, Azakie A. Ross-
konno and endocardial ﬁbroelastosis resection
after hybrid stage I palliation in infancy: successful
staged left-ventricular rehabilitation and conver-
sion to biventricular circulation after fetal diag-
nosis of aortic stenosis. Pediatr Cardiol 2010;32:
211–4.
25. Pedra SR, Peralta CF, Crema L, Jatene IB, da
Costa RN, Pedra CA. Fetal interventions for
congenital heart disease in Brazil. Pediatr Cardiol
2014;35:399–405.
26. Quintero RA, Huhta J, Suh E, Chmait R,
Romero R, Angel J. In utero cardiac fetal
surgery: laser atrial septotomy in the treatment
of hypoplastic left heart syndrome with intact
atrial septum. Am J Obstet Gynecol 2005;193:
1424–8.27. Freud LR, McElhinney DB, Marshall AC, et al.
Fetal aortic valvuloplasty for evolving hypoplastic
left heart syndrome: postnatal outcomes of the
ﬁrst 100 patients. Circulation 2014;130:638–45.
28. Arzt W, Wertaschnigg D, Veit I, Klement F,
Gitter R, Tulzer G. Intrauterine aortic valvuloplasty
in fetuses with critical aortic stenosis: experience
and results of 24 procedures. Ultrasound Obstet
Gynecol 2011;37:689–95.
29. McElhinney DB, Marshall AC, Wilkins-Haug LE,
et al. Predictors of technical success and postnatal
biventricular outcome after in utero aortic valvulo-
plasty for aortic stenosis with evolving hypo-
plastic left heart syndrome. Circulation 2009;120:
1482–90.
30. Golombeck K, Ball RH, Lee H, et al. Maternal
morbidity after maternal-fetal surgery. Am J
Obstet Gynecol 2006;194:834–9.
31. Jacobs JP, O’Brien SM, Pasquali SK, et al.
Variation in outcomes for benchmark operations:
an analysis of the Society of Thoracic Surgeons
Congenital Heart Surgery Database. Ann Thorac
Surg 2011;92:2184–91, discussion 2191–2.
32. Vida VL, Bacha EA, Larrazabal A, et al. Hypo-
plastic left heart syndrome with intact or highly
restrictive atrial septum: surgical experience from
a single center. Ann Thorac Surg 2007;84:581–5,
discussion 586.
33. Arzt W, Tulzer G, Aigner M, Mair R, Hafner E.
Invasive intrauterine treatment of pulmonary
atresia/intact ventricular septum with heart fail-
ure. Ultrasound Obstet Gynecol 2003;21:186–8.KEY WORDS congenital heart defects,
fetal cardiac intervention,
fetal echocardiography, valvuloplasty
APPENDIX For a complete list of IFCIR
contributors and the data sheets, please see
the online version of this article.
